Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 2/3 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Thoracic 1

Conditions

Nausea 4Vomiting 3Breast Neoplasms 3Neoplasms 2Lung Neoplasms 1

Interventions

Dexamethasone 29Aprepitant 24Palonosetron 20Ondansetron 20Calcium Dobesilate 13Olanzapine 12Granisetron 11Therapeutics 7fosaprepitant 6Doxorubicin 6Cyclophosphamide 6dexamethasone acetate 5netupitant 4Vincristine 4dolasetron 3Yoga 3Tropisetron 3Surveys and Questionnaires 3Psychiatric Rehabilitation 3Prochlorperazine 3Metoclopramide 3Lorazepam 3Dronabinol 3Acupressure 3peppermint oil 2netupitant, palosentron drug combination 2ginger extract 2dexamethasone 21-phosphate 2Sugars 2Rituximab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Nausea × netupitant × Clear all
NCT03040726 2023-10-17

Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer

M.D. Anderson Cancer Center

Phase 2/3 Completed
53 enrolled 15 charts

Nausea, Neoplasms, Vomiting

NCT04669132 2022-02-23

OLNEPA

Instituto Brasileiro de Controle do Cancer

Phase 2 Completed
50 enrolled
Breast

Breast Neoplasms, Nausea

NCT04201769 2020-04-03

LUNG-NEPA

Consorzio Oncotech

Phase 3 Unknown
261 enrolled
Thoracic

Lung Neoplasms, Nausea, Vomiting

NCT03862144 2019-03-05

GIM15-NEPA

Consorzio Oncotech

Phase 2 Completed
150 enrolled
Breast

Breast Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡